These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3295626)
1. Interferon alpha in the treatment of AIDS-associated Kaposi's sarcoma. Kern P; Meigel W; Rácz P; Gottesleben A; Dettke T; Dietrich M Onkologie; 1987 Feb; 10(1):50-2. PubMed ID: 3295626 [TBL] [Abstract][Full Text] [Related]
2. A phase I study of recombinant human interferon-alpha 2a or human lymphoblastoid interferon-alpha n1 and concomitant zidovudine in patients with AIDS-related Kaposi's sarcoma. Fischl MA; Uttamchandani RB; Resnick L; Agarwal R; Fletcher MA; Patrone-Reese J; Dearmas L; Chidekel J; McCann M; Myers M J Acquir Immune Defic Syndr (1988); 1991; 4(1):1-10. PubMed ID: 1670585 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma and the acquired immunodeficiency syndrome: treatment with high and low doses of recombinant leukocyte A interferon. Real FX; Oettgen HF; Krown SE J Clin Oncol; 1986 Apr; 4(4):544-51. PubMed ID: 3958767 [TBL] [Abstract][Full Text] [Related]
4. [Interferon alpha 2C in the treatment of 2 patients with AIDS-associated Kaposi sarcoma]. Steger G; Dittrich C; Eichler HG; Flener R; Moser K Wien Klin Wochenschr; 1987 Feb; 99(4):120-3. PubMed ID: 3577187 [TBL] [Abstract][Full Text] [Related]
5. Beta-interferon therapy in patients with poor-prognosis Kaposi sarcoma related to the acquired immunodeficiency syndrome (AIDS). A phase II trial with preliminary evidence of antiviral activity and low incidence of opportunistic infections. Miles SA; Wang HJ; Cortes E; Carden J; Marcus S; Mitsuyasu RT Ann Intern Med; 1990 Apr; 112(8):582-9. PubMed ID: 2109563 [TBL] [Abstract][Full Text] [Related]